Ben Goldacre | Guardian | 21 September 2012 Drugs are tested by manufacturers, in poorly designed trials, on small numbers of unrepresentative patients. Unsurprisingly, these trials often produce results that favour the manufacturer. Those that don't are buried Comments Monica Ceberio | El País | 17 September 2012 Spain holds on to tiny islets and crags off Morocco's coast. They have no strategic value, but Madrid fears a slippery slope leading to Ceuta, Melilla, the Canaries if it gives them up. African migrants see them as a way into Europe Comments Peggy Noonan | WSJ | 21 September 2012 Romney is losing it. "The candidate cannot oversee strategy, statements, speechwriting, ads. He shouldn't be debating what statistic to put on slide four of the Powerpoint presentation. He has to learn to trust others—many others" Comments Tanya Marie Luhrmann | Wilson Quarterly | 17 September 2012 "If you have dark skin, your risk of falling victim to schizophrenia increases as your neighborhood whitens." It afflicts migrants, city dwellers, and the poor disproportionately. A simple biomedical approach now looks flawed Comments Jonathan Weil | Bloomberg | 20 September 2012 System known as risk-weighting is farcical. It means banks can make assets disappear from their balance sheets. Deutsche had a reason for making 83% of its assets disappear in this way but the notion that they're riskless is absurd Comments Peter Coy | Businessweek | 19 September 2012 Euro crisis exposes fault lines within countries, as well as between countries. Regional interests and histories collide. "It’s not just Greece vs Germany. It’s Sicily vs Lombardy, Berlin vs Bavaria, Andalusia vs Catalonia" Comments | 
